XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net Revenue $ 11,756 $ 7,454 $ 32,901 $ 22,898
Cost of Goods Sold 2,795 1,753 7,756 5,325
Gross Profit 8,961 5,701 25,145 17,573
Selling, General and Administrative Expenses 15,077 8,492 38,428 25,368
Research and Development Expenses 1,525 1,090 4,514 3,322
Operating Loss (7,641) (3,881) (17,797) (11,117)
Other Expense        
Interest expense, net 78 316 661 925
Change in fair value of convertible notes, net 2,217 0 2,217 0
Change in fair value of Series E purchase option 0 0 11,719 0
Other expense (income), net (1,207) (142) 193 (215)
Total Other Expense 1,088 174 14,790 710
Loss before income tax expense (8,729) (4,055) (32,587) (11,827)
Income Tax Expense 0 0 0 0
Net Loss (8,729) (4,055) (32,587) (11,827)
Other Comprehensive (loss), net        
Unrealized gain (loss) on marketable securities (43) 61 (158) 46
Total Other Comprehensive loss (income), net (43) 61 (158) 46
Comprehensive loss $ (8,772) $ (3,994) $ (32,745) $ (11,781)
Net loss per share attributed to common stock – basic and diluted:        
Net loss per share (in dollars per share) $ (0.64) $ (68.31) $ (7.00) $ (203.81)
Net loss per share (in dollars per share) $ (0.64) $ (68.31) $ (7.00) $ (203.81)
Weighted average shares outstanding        
Weighted average common shares outstanding – basic (in shares) 13,604,556 59,372 4,652,825 58,031
Weighted average common shares outstanding – diluted (in shares) 13,604,556 59,372 4,652,825 58,031